Developer docs
API playgroundTry for free, no card

Search company profiles

Catapharma Group

Full company profile

uuid00381ds

Namestring
Catapharma Group
Legal namestring
Catapharma Group
Websiteurl
catapharma.com
Company typeenum
Private
Founded yearint
1986
Descriptiontext

Catapharma Group is a privately-held, India-based specialty chemical manufacturer specializing in liquid-phase catalytic hydrogenation and a defined portfolio of related transformations (oxidation, N- and O-alkylation, nitrosation, low-temperature nitration, esterification, ethoxylation). Founded in 1986 and headquartered in Nashik, Maharashtra, the company operates two manufacturing sites at Sinnar (Nashik) and Erandol (Jalgaon) and reports 160+ dedicated experts with 40+ years of chemistry and process expertise. Its product catalog spans ten chemical categories — piperazine derivatives, catechol derivatives, aliphatic amines, benzylamine derivatives, cyclen derivatives (including DOTA for MRI contrast agents), amino acids (including tranexamic acid derivatives), cyclohexylamine derivatives, toluidine derivatives, piperidine derivatives, and a basket of other intermediates — alongside a Custom Synthesis Services offering that uses pilot-plant capabilities to take customer-specific chemistries from lab to commercial scale. The company is also EcoVadis Bronze (2023), EU REACH, Halal, and Kosher certified, positioning it as a qualified supplier for regulated pharmaceutical and life-sciences buyers.

The business is B2B and sales-led, with all commercial activity routed through direct quote requests on the company website against lead times ranging from 1-3 weeks (Regular) to 4-6 weeks (Against Order) and longer for R&D / Pilot Plant engagements. Pricing is fully quote-based and not publicly disclosed, consistent with custom intermediate supply to enterprise buyers. Two revenue streams are evident: catalog pharmaceutical intermediate sales (treated as one-time product transactions in the source data) and Custom Synthesis Services (treated as professional services). Distribution is direct to enterprise accounts, with no channel intermediaries, supplying in drums, IBC tanks, and ISO tank packaging.

The company serves three vertical segments: pharmaceutical industry (primary, including API intermediates and synthesis building blocks), agrochemical industry (crop protection intermediates), and perfumery industry (aromatic fine chemicals). Its named customer roster includes global pharma majors — Pfizer, Sanofi Aventis, Sandoz, Viatris, Mylan — alongside leading Indian generic manufacturers (Cipla, Dr. Reddy's, Lupin, Glenmark, Macleods, Aurobindo, Piramal, Torrent, Alembic, Jubilant, MSN Labs, Neuland) and specialty chemical customers (Saltigo, Sumitomo, Cambrex, UBE Industries, Corden Pharma, SRF, Endura, DSM Firmenich, Olon). The company claims presence in 30+ countries across four continents.

Short descriptiontext

Catapharma Group is a privately-held, India-based specialty chemical manufacturer specializing in liquid-phase catalytic hydrogenation and related transformations, producing pharmaceutical, agrochemical, and perfumery intermediates from two Maharashtra manufacturing sites for global enterprise buyers.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersMumbai, India
HQ citystring
Mumbai
HQ countrystring
India
HQ regionstring
Asia
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pharmaceutical intermediates, specialty chemicals manufacturing, catalytic hydrogenation services, custom synthesis intermediates, fine chemicals B2B
Industry2 codes
PRIMARYHLAGAHAH
Custom Intermediates & Advanced Intermediates Manufacturing
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/API & Small-Molecule Development/Manufacturing Services
SECONDARYHLAIABAG
Generic APIs & Intermediates (Active Ingredients)
NAICS code2 codes
  • Chemical Manufacturing325
  • All Other Basic Organic Chemical Manufacturing325199
SIC code2 codes
  • Medicinal Chemicals & Botanical Products2833
  • Industrial Organic Chemicals2860
Product category
Pharmaceutical Intermediates & Fine Chemicals Manufacturing
No data
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Pharmaceutical Intermediates Sales
TypeOne Time License
Description

Sale of catalog specialty chemical intermediates across multiple categories including piperazine derivatives, catechol derivatives, aliphatic amines, benzylamine derivatives, cyclen derivatives, and amino acids to pharmaceutical, agrochemical, and perfumery customers

catapharma.com
2Custom Synthesis Services
TypeProfessional Services
Description

Tailored synthesis services leveraging pilot plant capabilities for complex chemistries, supporting customer-specific requirements at various scales

catapharma.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Operations, Personnel, Infrastructure, Technology or R&D, Marketing or Sales
Pricing details1 tier
1B2B quote-based pricing for specialty chemical intermediates
ModelOtherBilling cadencePay-as-you-go
Notes

No public pricing available. All products require quote requests. Availability types include Against Order, Regular, R&D, and Pilot Plant with varying lead times.

catapharma.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Catapharma Group manufactures and sells specialty chemical intermediates for pharmaceutical, agrochemical, and perfumery industries, organized across ten product categories including piperazine derivatives, catechol derivatives, aliphatic amines, benzylamine derivatives, cyclen derivatives, amino acids, cyclohexylamine derivatives, toluidine derivatives, piperidine derivatives, and other intermediates. The company also offers custom synthesis services using pilot plant capabilities to scale complex chemistries. Its core competency is liquid-phase catalytic hydrogenation and related chemical transformations, producing high-purity intermediates at two manufacturing sites in India.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 40+ years of continuous operation in specialty chemical manufacturing
+2 more records
Product overview1 text field

Catapharma Group is a specialty chemical manufacturer with 40+ years of expertise in liquid-phase catalytic hydrogenation and related transformations, supplying advanced pharmaceutical intermediates to customers worldwide. The company operates two manufacturing sites in India and serves customers in 30+ countries across four continents. Their product portfolio consists of ten major chemical categories: Piperazine Derivatives (30+ products), Catechol Derivatives, Aliphatic Amines, Benzylamine Derivatives, Cyclohexylamine Derivatives, Toluidine Derivatives, Cyclen Derivatives (including DOTA for MRI contrast agents), Piperidine Derivatives, Amino Acids (including Tranexamic Acid derivatives), and Other Intermediates. The company also offers Custom Synthesis Services for complex chemistries using their pilot plant capabilities. Core technical competencies include catalytic hydrogenation, oxidation, N-alkylation, O-alkylation, nitrosation, low-temperature nitration, esterification, and ethoxylation. Customers include major global pharmaceutical companies such as Cipla, Dr. Reddy's, Pfizer, Sanofi, Sandoz, Viatris, Lupin, and Glenmark.

Product and service11 records
1Piperazine Derivatives
CategorySpecialty Chemical Intermediates — Piperazine Derivatives
Description

Substituted piperazine compounds and derivatives for pharmaceutical applications, including N-Methyl Piperazine, N,N'-Dimethyl Piperazine, 1-Amino-4-Methyl Piperazine, N-Cyclopentyl Piperazine, 1-Amino-4-Cyclopentyl Piperazine, N-Ethyl Piperazine, N-i-Propyl Piperazine, N-i-Butyl Piperazine, N-Cyclohexyl Piperazine, and N-(Hydroxyethyl) Piperazine, supplied as intermediates to pharmaceutical manufacturers.

2Catechol Derivatives
CategorySpecialty Chemical Intermediates — Catechol Derivatives
Description

Methylenedioxy and methoxy benzene compounds for agrochemical and perfumery applications, including 1,2-Methylenedioxy Benzene, Sesamol, Piperonal, Veratrole, and Helional, supplied to specialty chemical and fragrance manufacturers.

3Aliphatic Amines
CategorySpecialty Chemical Intermediates — Aliphatic Amines
Description

Primary, secondary, and tertiary amines for water treatment and catalysts, including N,N-Dimethyl-1,3-Propanediamine, N,N-Diisopropyl Ethylamine (DIPEA), and various alkoxypropylamines, supplied to industrial and chemical customers.

4Benzylamine Derivatives
CategorySpecialty Chemical Intermediates — Benzylamine Derivatives
Description

High-purity benzylamine derivatives for pharmaceutical synthesis, including N-Benzyl-Iso-Propylamine, N-Methyl Benzylamine, N,N-Dimethyl Benzylamine (BDMA), and N-Benzyl Ethanolamine, supplied as intermediates to pharmaceutical manufacturers.

5Cyclen Derivatives
CategorySpecialty Chemical Intermediates — Cyclen Derivatives
Description

Macrocyclic tetraaza compounds used for MRI contrast agents and research applications, including 1,4,7,10-Tetraazacyclododecane (Cyclen), Tetrabenzyl Cyclen (TBC), and DOTA, supplied to pharmaceutical and research customers.

6Amino Acids
CategorySpecialty Chemical Intermediates — Amino Acids
Description

Cyclohexane carboxylic acid derivatives and specialized amino acids, including trans-N-BOC-4-Amino Cyclohexane Carboxylic Acid, 4-(Aminomethyl) Cyclohexane Carboxylic Acid (Tranexamic Acid), and various stereoisomers, supplied as pharmaceutical intermediates.

7Cyclohexylamine Derivatives
CategorySpecialty Chemical Intermediates — Cyclohexylamine Derivatives
Description

N-substituted cyclohexylamine compounds for pharmaceutical applications, including N-Methyl Cyclohexylamine and N-Ethyl Cyclohexylamine (Vulkacit HX), supplied as intermediates to pharmaceutical manufacturers.

8Toluidine Derivatives
CategorySpecialty Chemical Intermediates — Toluidine Derivatives
Description

N-alkyl toluidine compounds for chemical synthesis, including N-Ethyl-m-Toluidine, N-Ethyl-o-Toluidine, N,N-Dimethyl-m-Toluidine, and N-Methyl-m-Toluidine, supplied as intermediates to chemical and pharmaceutical manufacturers.

9Piperidine Derivatives
CategorySpecialty Chemical Intermediates — Piperidine Derivatives
Description

N-substituted piperidine compounds supplied as pharmaceutical intermediates, including N-Methyl Piperidine, N-Ethyl Piperidine, N-Amino Piperidine, and Ethyl Nipecotate.

10Other Intermediates
CategorySpecialty Chemical Intermediates — Other
Description

Specialized chemical intermediates including N-Aminomorpholine, Benzhydrol, Diamino Naphthalenes, Dihydro isobenzofurans, and Cyclohexanediones for various pharmaceutical and chemical applications.

11Custom Synthesis Services
CategoryCustom Synthesis Services
Description

Tailored synthesis services that leverage pilot plant capabilities to scale complex chemistries beyond the catalog portfolio, supporting customer-specific requirements at various scales for pharmaceutical, agrochemical, and perfumery customers.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Recent move4 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Diversified Japanese chemical company with specialty intermediates across pharma and agro. Broader portfolio but overlapping chemistries, and listed as a Catapharma customer.

TypeDirect peer
Description

Indian CDMO focused on API intermediates and custom synthesis for global pharma, including complex chemistries analogous to Catapharma's hydrogenation and alkylation portfolio. Strong overlap in customer base and product positioning.

TypeDirect peer
Description

Indian specialty chemicals and intermediates manufacturer serving pharma, agro, and animal health. Comparable scale, geography, and product portfolio breadth.

TypeDirect peer
Description

Indian API and intermediates manufacturer with deep custom synthesis capability supplying global generics and innovators. Closest comparable on geography, customer mix (large generics + innovators), and intermediates-led business model.

TypeDirect peer
Description

Custom synthesis subsidiary of Lanxess specializing in complex organic intermediates for agro, pharma, and specialty chemicals. Directly comparable in custom synthesis positioning and is listed as a Catapharma customer.

TypeDirect peer
Description

Global CDMO with API intermediates and custom synthesis across multiple therapeutic categories. Directly comparable on offering breadth and B2B pharma customer model.

TypeBroad incumbent
Description

Large Indian generics manufacturer with vertically integrated intermediates and API capabilities. Competes on intermediates supply and is also a Catapharma customer, operating at meaningfully larger scale.

TypeDirect peer
Description

API and custom synthesis manufacturer (acquired by Permira) serving global pharma with intermediates and drug substance capabilities. Mirrors Catapharma's enterprise customer model and is also listed as a customer of Catapharma.

TypeDirect peer
Description

Indian CDMO offering API intermediates, custom synthesis, and process development for innovator and generic pharma. Comparable scale and chemistry scope including hydrogenation and complex transformations.

TypeDirect peer
Description

Indian CDMO and intermediates manufacturer (formerly Jubilant Life Sciences) supplying global pharma. Operates overlapping hydrogenation, alkylation, and custom synthesis capabilities and is also a named customer of Catapharma.

Market position
Strengths1 record

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers26 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Catapharma Group

Pharmaceutical Intermediates & Fine Chemicals Manufacturingcatapharma.com

Catapharma Group is a privately-held, India-based specialty chemical manufacturer specializing in liquid-phase catalytic hydrogenation and related transformations, producing pharmaceutical, agrochemical, and perfumery intermediates from two Maharashtra manufacturing sites for global enterprise buyers.

What Catapharma Group does

Catapharma Group is a privately-held, India-based specialty chemical manufacturer specializing in liquid-phase catalytic hydrogenation and a defined portfolio of related transformations (oxidation, N- and O-alkylation, nitrosation, low-temperature nitration, esterification, ethoxylation). Founded in 1986 and headquartered in Nashik, Maharashtra, the company operates two manufacturing sites at Sinnar (Nashik) and Erandol (Jalgaon) and reports 160+ dedicated experts with 40+ years of chemistry and process expertise. Its product catalog spans ten chemical categories — piperazine derivatives, catechol derivatives, aliphatic amines, benzylamine derivatives, cyclen derivatives (including DOTA for MRI contrast agents), amino acids (including tranexamic acid derivatives), cyclohexylamine derivatives, toluidine derivatives, piperidine derivatives, and a basket of other intermediates — alongside a Custom Synthesis Services offering that uses pilot-plant capabilities to take customer-specific chemistries from lab to commercial scale. The company is also EcoVadis Bronze (2023), EU REACH, Halal, and Kosher certified, positioning it as a qualified supplier for regulated pharmaceutical and life-sciences buyers.

The business is B2B and sales-led, with all commercial activity routed through direct quote requests on the company website against lead times ranging from 1-3 weeks (Regular) to 4-6 weeks (Against Order) and longer for R&D / Pilot Plant engagements. Pricing is fully quote-based and not publicly disclosed, consistent with custom intermediate supply to enterprise buyers. Two revenue streams are evident: catalog pharmaceutical intermediate sales (treated as one-time product transactions in the source data) and Custom Synthesis Services (treated as professional services). Distribution is direct to enterprise accounts, with no channel intermediaries, supplying in drums, IBC tanks, and ISO tank packaging.

The company serves three vertical segments: pharmaceutical industry (primary, including API intermediates and synthesis building blocks), agrochemical industry (crop protection intermediates), and perfumery industry (aromatic fine chemicals). Its named customer roster includes global pharma majors — Pfizer, Sanofi Aventis, Sandoz, Viatris, Mylan — alongside leading Indian generic manufacturers (Cipla, Dr. Reddy's, Lupin, Glenmark, Macleods, Aurobindo, Piramal, Torrent, Alembic, Jubilant, MSN Labs, Neuland) and specialty chemical customers (Saltigo, Sumitomo, Cambrex, UBE Industries, Corden Pharma, SRF, Endura, DSM Firmenich, Olon). The company claims presence in 30+ countries across four continents.

Catapharma Group firmographics

Firmographics
Name
Catapharma Group
Legal name
Catapharma Group
Website
https://catapharma.com
Company type
Private
Founded year
1986
Operating status
Operating
Headcount range
51–100 employees
Short description
Catapharma Group is a privately-held, India-based specialty chemical manufacturer specializing in liquid-phase catalytic hydrogenation and related transformations, producing pharmaceutical, agrochemical, and perfumery intermediates from two Maharashtra manufacturing sites for global enterprise buyers.
Ownership category
akta.pro rank

Catapharma Group industry classification

Industry
Product category
Pharmaceutical Intermediates & Fine Chemicals Manufacturing
NAICS
Chemical Manufacturing (325), All Other Basic Organic Chemical Manufacturing (325199)
SIC
Medicinal Chemicals & Botanical Products (2833), Industrial Organic Chemicals (2860)
akta.pro industry
PRIMARYHLAGAHAH
Custom Intermediates & Advanced Intermediates Manufacturing
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/API & Small-Molecule Development/Manufacturing Services
SECONDARYHLAIABAG
Generic APIs & Intermediates (Active Ingredients)

Keywords

  • Pharmaceutical intermediates
  • Specialty chemicals manufacturing
  • Catalytic hydrogenation services
  • Custom synthesis intermediates
  • Fine chemicals B2B

Where Catapharma Group is headquartered

Location

Headquarters

HQ city
Mumbai
HQ country
India
HQ region
Asia

Offices3 records

Markets served

Catapharma Group business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Personnel, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

  1. Pharmaceutical Intermediates Sales: Sale of catalog specialty chemical intermediates across multiple categories including piperazine derivatives, catechol derivatives, aliphatic amines, benzylamine derivatives, cyclen derivatives, and amino acids to pharmaceutical, agrochemical, and perfumery customers
  2. Custom Synthesis Services: Tailored synthesis services leveraging pilot plant capabilities for complex chemistries, supporting customer-specific requirements at various scales

Pricing tiers

ModelBillingPrice
OtherPay-as-you-goB2B quote-based pricing for specialty chemical intermediates

Go-to-market motion1 record

Distribution channels2 records

Marketing channels3 records

Catapharma Group product offering

Product offering

Core offering

Catapharma Group manufactures and sells specialty chemical intermediates for pharmaceutical, agrochemical, and perfumery industries, organized across ten product categories including piperazine derivatives, catechol derivatives, aliphatic amines, benzylamine derivatives, cyclen derivatives, amino acids, cyclohexylamine derivatives, toluidine derivatives, piperidine derivatives, and other intermediates. The company also offers custom synthesis services using pilot plant capabilities to scale complex chemistries. Its core competency is liquid-phase catalytic hydrogenation and related chemical transformations, producing high-purity intermediates at two manufacturing sites in India.

Product overview

Catapharma Group is a specialty chemical manufacturer with 40+ years of expertise in liquid-phase catalytic hydrogenation and related transformations, supplying advanced pharmaceutical intermediates to customers worldwide. The company operates two manufacturing sites in India and serves customers in 30+ countries across four continents. Their product portfolio consists of ten major chemical categories: Piperazine Derivatives (30+ products), Catechol Derivatives, Aliphatic Amines, Benzylamine Derivatives, Cyclohexylamine Derivatives, Toluidine Derivatives, Cyclen Derivatives (including DOTA for MRI contrast agents), Piperidine Derivatives, Amino Acids (including Tranexamic Acid derivatives), and Other Intermediates. The company also offers Custom Synthesis Services for complex chemistries using their pilot plant capabilities. Core technical competencies include catalytic hydrogenation, oxidation, N-alkylation, O-alkylation, nitrosation, low-temperature nitration, esterification, and ethoxylation. Customers include major global pharmaceutical companies such as Cipla, Dr. Reddy's, Pfizer, Sanofi, Sandoz, Viatris, Lupin, and Glenmark.

Differentiator

Problem solved

Functional benefit

Products and services

  • Piperazine Derivatives Substituted piperazine compounds and derivatives for pharmaceutical applications, including N-Methyl Piperazine, N,N'-Dimethyl Piperazine, 1-Amino-4-Methyl Piperazine, N-Cyclopentyl Piperazine, 1-Amino-4-Cyclopentyl Piperazine, N-Ethyl Piperazine, N-i-Propyl Piperazine, N-i-Butyl Piperazine, N-Cyclohexyl Piperazine, and N-(Hydroxyethyl) Piperazine, supplied as intermediates to pharmaceutical manufacturers.
  • Catechol Derivatives Methylenedioxy and methoxy benzene compounds for agrochemical and perfumery applications, including 1,2-Methylenedioxy Benzene, Sesamol, Piperonal, Veratrole, and Helional, supplied to specialty chemical and fragrance manufacturers.
  • Aliphatic Amines Primary, secondary, and tertiary amines for water treatment and catalysts, including N,N-Dimethyl-1,3-Propanediamine, N,N-Diisopropyl Ethylamine (DIPEA), and various alkoxypropylamines, supplied to industrial and chemical customers.
  • Benzylamine Derivatives High-purity benzylamine derivatives for pharmaceutical synthesis, including N-Benzyl-Iso-Propylamine, N-Methyl Benzylamine, N,N-Dimethyl Benzylamine (BDMA), and N-Benzyl Ethanolamine, supplied as intermediates to pharmaceutical manufacturers.
  • Cyclen Derivatives Macrocyclic tetraaza compounds used for MRI contrast agents and research applications, including 1,4,7,10-Tetraazacyclododecane (Cyclen), Tetrabenzyl Cyclen (TBC), and DOTA, supplied to pharmaceutical and research customers.
  • Amino Acids Cyclohexane carboxylic acid derivatives and specialized amino acids, including trans-N-BOC-4-Amino Cyclohexane Carboxylic Acid, 4-(Aminomethyl) Cyclohexane Carboxylic Acid (Tranexamic Acid), and various stereoisomers, supplied as pharmaceutical intermediates.
  • Cyclohexylamine Derivatives N-substituted cyclohexylamine compounds for pharmaceutical applications, including N-Methyl Cyclohexylamine and N-Ethyl Cyclohexylamine (Vulkacit HX), supplied as intermediates to pharmaceutical manufacturers.
  • Toluidine Derivatives N-alkyl toluidine compounds for chemical synthesis, including N-Ethyl-m-Toluidine, N-Ethyl-o-Toluidine, N,N-Dimethyl-m-Toluidine, and N-Methyl-m-Toluidine, supplied as intermediates to chemical and pharmaceutical manufacturers.
  • Piperidine Derivatives N-substituted piperidine compounds supplied as pharmaceutical intermediates, including N-Methyl Piperidine, N-Ethyl Piperidine, N-Amino Piperidine, and Ethyl Nipecotate.
  • Other Intermediates Specialized chemical intermediates including N-Aminomorpholine, Benzhydrol, Diamino Naphthalenes, Dihydro isobenzofurans, and Cyclohexanediones for various pharmaceutical and chemical applications.
  • Custom Synthesis Services Tailored synthesis services that leverage pilot plant capabilities to scale complex chemistries beyond the catalog portfolio, supporting customer-specific requirements at various scales for pharmaceutical, agrochemical, and perfumery customers.

Quantifiable outcome

  • 40+ years of continuous operation in specialty chemical manufacturing
  • +2 more outcomes

Companies that use Catapharma Group

Customer profile

Named customers26 records

Segments3 records

Ideal customer profiles3 records

Catapharma Group technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

Catapharma Group partnerships and signals

Strategic signal

Scale indicators4 records

Recent moves4 records

Expansion highlights5 records

Catapharma Group competitors and assessment

Company assessment

Broad incumbents

  • Sumitomo Chemical: Diversified Japanese chemical company with specialty intermediates across pharma and agro. Broader portfolio but overlapping chemistries, and listed as a Catapharma customer.
  • Aurobindo Pharma: Large Indian generics manufacturer with vertically integrated intermediates and API capabilities. Competes on intermediates supply and is also a Catapharma customer, operating at meaningfully larger scale.

Direct peers

  • Neuland Laboratories: Indian CDMO focused on API intermediates and custom synthesis for global pharma, including complex chemistries analogous to Catapharma's hydrogenation and alkylation portfolio. Strong overlap in customer base and product positioning.
  • Hikal Ltd: Indian specialty chemicals and intermediates manufacturer serving pharma, agro, and animal health. Comparable scale, geography, and product portfolio breadth.
  • Divi's Laboratories: Indian API and intermediates manufacturer with deep custom synthesis capability supplying global generics and innovators. Closest comparable on geography, customer mix (large generics + innovators), and intermediates-led business model.
  • Saltigo (Lanxess): Custom synthesis subsidiary of Lanxess specializing in complex organic intermediates for agro, pharma, and specialty chemicals. Directly comparable in custom synthesis positioning and is listed as a Catapharma customer.
  • Piramal Pharma Solutions: Global CDMO with API intermediates and custom synthesis across multiple therapeutic categories. Directly comparable on offering breadth and B2B pharma customer model.
  • Cambrex: API and custom synthesis manufacturer (acquired by Permira) serving global pharma with intermediates and drug substance capabilities. Mirrors Catapharma's enterprise customer model and is also listed as a customer of Catapharma.
  • Sai Life Sciences: Indian CDMO offering API intermediates, custom synthesis, and process development for innovator and generic pharma. Comparable scale and chemistry scope including hydrogenation and complex transformations.
  • Jubilant Pharmova: Indian CDMO and intermediates manufacturer (formerly Jubilant Life Sciences) supplying global pharma. Operates overlapping hydrogenation, alkylation, and custom synthesis capabilities and is also a named customer of Catapharma.

Market position

Strengths1 record

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Catapharma Group compliance and trust

Trust signal

Compliance4 records

Catapharma Group financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Catapharma Group leadership team

Management profile

Number of profiles

Catapharma Group funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Catapharma Group M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Catapharma Group

What does Catapharma Group do?

Catapharma Group manufactures and sells specialty chemical intermediates for pharmaceutical, agrochemical, and perfumery industries, organized across ten product categories including piperazine derivatives, catechol derivatives, aliphatic amines, benzylamine derivatives, cyclen derivatives, amino acids, cyclohexylamine derivatives, toluidine derivatives, piperidine derivatives, and other intermediates. The company also offers custom synthesis services using pilot plant capabilities to scale complex chemistries. Its core competency is liquid-phase catalytic hydrogenation and related chemical transformations, producing high-purity intermediates at two manufacturing sites in India.

Is Catapharma Group a public or private company?

Catapharma Group is a private company. It is classified as unknown and is currently operating.

When was Catapharma Group founded?

Catapharma Group was founded in 1986. It employs 51 to 100 people.

Where is Catapharma Group based?

Catapharma Group is headquartered in Mumbai, India, in the Asia region.

How does Catapharma Group make money?

Two revenue lines are on record. Pharmaceutical Intermediates Sales are the primary driver. The others are custom Synthesis Services.

Who are Catapharma Group's main competitors?

Broad incumbents on record are Sumitomo Chemical and Aurobindo Pharma. Direct peers are Neuland Laboratories, Hikal Ltd, Divi's Laboratories, Saltigo (Lanxess), Piramal Pharma Solutions, Cambrex, Sai Life Sciences and Jubilant Pharmova.

Does Catapharma Group have an API?

No public API is recorded for Catapharma Group.

What industry is Catapharma Group in?

Catapharma Group's product category is Pharmaceutical Intermediates & Fine Chemicals Manufacturing. Its primary akta.pro industry code is HLAGAHAH, Custom Intermediates & Advanced Intermediates Manufacturing, with a secondary code of HLAIABAG, Generic APIs & Intermediates (Active Ingredients). Its NAICS code is 325 and its SIC code is 2833.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales